Cargando…
3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
Autores principales: | Chen, Yuzhong, Wei, Li, Zhang, Xiaojing, Liu, Xianfu, Chen, Yansong, Zhang, Song, Zhou, Lanzhu, Li, Qixiang, Pan, Qiong, Zhao, Surong, Liu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808700/ https://www.ncbi.nlm.nih.gov/pubmed/35039880 http://dx.doi.org/10.3892/or.2022.8264 |
Ejemplares similares
-
3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
por: Chen, Yuzhong, et al.
Publicado: (2018) -
Ppm1b Negatively Regulates 3-Bromopyruvate Induced Necroptosis in Breast Cancer Cells
por: Sun, Yiming, et al.
Publicado: (2021) -
Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer
por: Kim, Se-Lim, et al.
Publicado: (2019) -
Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer
por: Sun, Yiming, et al.
Publicado: (2015) -
Corrigendum to “Melatonin Attenuates Diabetic Myocardial Microvascular Injury through Activating the AMPK/SIRT1 Signaling Pathway”
por: Wang, Bin, et al.
Publicado: (2021)